Oral Drug Delivery Market To 2017: Fill & Download for Free

Pharmaceutical Packaging Market To Reach Worth US$ 130.73 Bn By 2025According to the latest report published by Credence Research, Inc. “Pharmaceutical Packaging Market- Growth, Future Prospects and Competitive Analysis, 2017-2025,” the global pharmaceutical packaging market was valued at US$ 70.87 Bn in 2016, and is expected to reach US$ 130.73 Bn by 2025, expanding at a CAGR of 8.8% from 2017 to 2025.Market InsightsGlobal pharmaceutical packaging market comprises study of all the materials used for packaging of the pharmaceuticals. The global market includes the packaging carried out by the manufacturing companies as well as drugs packed on the contract basis. Numerous materials are utilized for the packaging of the drugs including plastics, polymers, paper, glass, aluminum foil. Due to the increasing global disease burden, manufacturing of the pharmaceuticals is rising, which leads to the growth of global pharmaceutical packaging material.Increased research & development for the novel and innovative packaging materials, increased healthcare expenditure by the government, growth in generic drugs market and demand for eco-friendly and reusable packaging materials are some of the factors that are driving the market. Other driving factors include the establishment of new pharmaceutical manufacturing plants in developing countries and increase in trend of contract packaging. Growing cost of raw materials used in pharmaceutical packaging hinders the global pharmaceutical packaging market.Download Free brochure of research report with TOC and Figures @ https://www.credenceresearch.com/sample-request/58891Based on their types, the global pharmaceutical packaging market is segmented into ampules, blister packs, canisters, cartridges, IV bags, medical specialty bags, mini-jars, plastic bottles, pouches, sachets, syringes, tubes, vials and others. In terms of market value, plastic bottles segment leads the market followed by blister packs and pouches. On the basis of types of material, the global pharmaceutical packaging market is segmented into plastics & polymer, glass, aluminum foil, paper & paperboard, and others. Plastics segment leads the global market due to the preference of plastics over other segments of the market.Based on drug delivery method, the global pharmaceutical packaging market is segmented into oral drug packaging, pulmonary drug packaging, transdermal drug packaging, injectable drug packaging, nasal drug packaging and others. Oral drug packaging segment dominates the global pharmaceutical packaging market and is expected to maintain its dominance in the forecast period.On the basis of geographical regions, the global pharmaceutical packaging is categorized into North America, Asia Pacific, Europe, Latin America, and the Middle East and Africa. In terms of market value, North America dominates the global pharmaceutical packaging market. According to the market analysis, North America is expected to maintain its dominance in the forecast year. Asia Pacific market segment is escalating due to improved healthcare services in the region. As the market is highly fragmented due to the presence of many manufacturing companies, there is no clear market leader. Some of the key players include Amcor, Ltd., Aptar Group, Inc., Baxter International, Inc., Becton Dickinson and Company, Bemis Healthcare Packaging, Berry Plastics Corporation, Capsugel, Inc., Gerresheimer AG, Graphic Packaging Group, MeadWestvaco Corporation, Owens-Illinois, RPC Group, Schott Pharmaceuticals Services, Inc., Sealed Air Corporation, Westrock and Catalent Pharma Solutions, Inc.TOC:Chapter 3. Pharmaceutical Packaging Market: Market Dynamics and Outlook3.1. Market Definition and Overview3.2. Drivers3.3. Challenges3.4. Opportunities3.5. Attractive Investment Proposition, by Geography3.6. Value Chain Analysis3.7. Porter’s Five Forces Model3.8. Competitive Landscape3.8.1. Competitive Landscape, by Key Players, 2016Chapter 4. Pharmaceutical Packaging Market, by Type, 2015 – 2025 (US$ Bn)4.1. Overview4.1.1. Attractive Investment Proposition, by Type, 20164.2. Ampules4.3. Blister Packs4.4. Canisters4.5. Cartridges4.6. IV Bags4.7. Medical Specialty Bags4.8. Mini-Jars4.9. Plastic Bottles4.10. Pouches4.11. Sachets4.12. Syringes4.13. Tubes4.14. Vials4.15. OthersChapter 5. Pharmaceutical Packaging Market, by Material, 2015 – 2025 (US$ Bn)5.1. Overview5.1.1. Attractive Investment Proposition, by Material, 20165.2. Plastics & Polymer5.3. Paper & Paper Board5.4. Glass5.5. Aluminum Foil5.6. OthersChapter 6. Pharmaceutical Packaging Market, by Drug Delivery Method, 2015 – 2025 (US$ Bn)6.1. Overview6.1.1. Attractive Investment Proposition, by Drug Delivery Method, 20166.2. Oral Drug packaging6.3. Pulmonary Drug Packaging6.4. Transdermal Drug Packaging6.5. Injectable Drug Packaging6.6. Nasal Drug Packaging6.7. OthersChapter 8. Company Profiles8.1. Amcor, Ltd.8.1.1. Business Description8.1.2. Financial Information (Subject to data availability)8.1.3. Application Portfolio8.1.4. Key Developments8.2. Aptar Group, Inc.8.3. Baxter International, Inc.8.4. Becton Dickinson and Company8.5. Bemis Healthcare Packaging8.6. Berry Plastics Corporation8.7. Capsugel, Inc.8.8. Gerresheimer AG8.9. Graphic Packaging Group8.10. MeadWestvaco Corporation ...Download Free brochure of research report with TOC and Figures @ https://www.credenceresearch.com/sample-request/58891

Pharmaceutical Packaging Market To Reach Worth US$ 130.73 Bn By 2025According to the latest report published by Credence Research, Inc. “Pharmaceutical Packaging Market- Growth, Future Prospects and Competitive Analysis, 2017-2025,” the global pharmaceutical packaging market was valued at US$ 70.87 Bn in 2016, and is expected to reach US$ 130.73 Bn by 2025, expanding at a CAGR of 8.8% from 2017 to 2025.Market InsightsGlobal pharmaceutical packaging market comprises study of all the materials used for packaging of the pharmaceuticals. The global market includes the packaging carried out by the manufacturing companies as well as drugs packed on the contract basis. Numerous materials are utilized for the packaging of the drugs including plastics, polymers, paper, glass, aluminum foil. Due to the increasing global disease burden, manufacturing of the pharmaceuticals is rising, which leads to the growth of global pharmaceutical packaging material.Increased research & development for the novel and innovative packaging materials, increased healthcare expenditure by the government, growth in generic drugs market and demand for eco-friendly and reusable packaging materials are some of the factors that are driving the market. Other driving factors include the establishment of new pharmaceutical manufacturing plants in developing countries and increase in trend of contract packaging. Growing cost of raw materials used in pharmaceutical packaging hinders the global pharmaceutical packaging market.Download Free brochure of research report with TOC and Figures @ https://www.credenceresearch.com/sample-request/58891Based on their types, the global pharmaceutical packaging market is segmented into ampules, blister packs, canisters, cartridges, IV bags, medical specialty bags, mini-jars, plastic bottles, pouches, sachets, syringes, tubes, vials and others. In terms of market value, plastic bottles segment leads the market followed by blister packs and pouches. On the basis of types of material, the global pharmaceutical packaging market is segmented into plastics & polymer, glass, aluminum foil, paper & paperboard, and others. Plastics segment leads the global market due to the preference of plastics over other segments of the market.Based on drug delivery method, the global pharmaceutical packaging market is segmented into oral drug packaging, pulmonary drug packaging, transdermal drug packaging, injectable drug packaging, nasal drug packaging and others. Oral drug packaging segment dominates the global pharmaceutical packaging market and is expected to maintain its dominance in the forecast period.On the basis of geographical regions, the global pharmaceutical packaging is categorized into North America, Asia Pacific, Europe, Latin America, and the Middle East and Africa. In terms of market value, North America dominates the global pharmaceutical packaging market. According to the market analysis, North America is expected to maintain its dominance in the forecast year. Asia Pacific market segment is escalating due to improved healthcare services in the region. As the market is highly fragmented due to the presence of many manufacturing companies, there is no clear market leader. Some of the key players include Amcor, Ltd., Aptar Group, Inc., Baxter International, Inc., Becton Dickinson and Company, Bemis Healthcare Packaging, Berry Plastics Corporation, Capsugel, Inc., Gerresheimer AG, Graphic Packaging Group, MeadWestvaco Corporation, Owens-Illinois, RPC Group, Schott Pharmaceuticals Services, Inc., Sealed Air Corporation, Westrock and Catalent Pharma Solutions, Inc.TOC:Chapter 3. Pharmaceutical Packaging Market: Market Dynamics and Outlook3.1. Market Definition and Overview3.2. Drivers3.3. Challenges3.4. Opportunities3.5. Attractive Investment Proposition, by Geography3.6. Value Chain Analysis3.7. Porter’s Five Forces Model3.8. Competitive Landscape3.8.1. Competitive Landscape, by Key Players, 2016Chapter 4. Pharmaceutical Packaging Market, by Type, 2015 – 2025 (US$ Bn)4.1. Overview4.1.1. Attractive Investment Proposition, by Type, 20164.2. Ampules4.3. Blister Packs4.4. Canisters4.5. Cartridges4.6. IV Bags4.7. Medical Specialty Bags4.8. Mini-Jars4.9. Plastic Bottles4.10. Pouches4.11. Sachets4.12. Syringes4.13. Tubes4.14. Vials4.15. OthersChapter 5. Pharmaceutical Packaging Market, by Material, 2015 – 2025 (US$ Bn)5.1. Overview5.1.1. Attractive Investment Proposition, by Material, 20165.2. Plastics & Polymer5.3. Paper & Paper Board5.4. Glass5.5. Aluminum Foil5.6. OthersChapter 6. Pharmaceutical Packaging Market, by Drug Delivery Method, 2015 – 2025 (US$ Bn)6.1. Overview6.1.1. Attractive Investment Proposition, by Drug Delivery Method, 20166.2. Oral Drug packaging6.3. Pulmonary Drug Packaging6.4. Transdermal Drug Packaging6.5. Injectable Drug Packaging6.6. Nasal Drug Packaging6.7. OthersChapter 8. Company Profiles8.1. Amcor, Ltd.8.1.1. Business Description8.1.2. Financial Information (Subject to data availability)8.1.3. Application Portfolio8.1.4. Key Developments8.2. Aptar Group, Inc.8.3. Baxter International, Inc.8.4. Becton Dickinson and Company8.5. Bemis Healthcare Packaging8.6. Berry Plastics Corporation8.7. Capsugel, Inc.8.8. Gerresheimer AG8.9. Graphic Packaging Group8.10. MeadWestvaco Corporation ...

The latest market report published by Credence Research, Inc. “Hereditary Angioedema Market was valued at US$ 1,750.2 Mn in 2016, and is expected to reach US$ 3,689.4 Mn by 2025 expanding at a CAGR of 8.19% from 2017 to 2025.Credence Research, the leading business intelligence provider, has published its latest research, "Hereditary Angioedema Market 2025", which gives insights into Hereditary Angioedema in the Global market. The report determines the market size for 2018, along with forecasts until 2025. It is built using data and information sourced from exclusive databases, primary and secondary research, and in-house analysis carried out by Credence Research’s team of industry experts.Market Insights:Hereditary angioedema is a rare autosomal dominant disorder and has disease epidemiology of one individual per 10,000 - 50,000 without major sex or ethnic differences. Hereditary angioedema has resulted in tremendous humanistic burden on patients in terms of poor physical and mental health causing a major setback on education, career, work productivity and socioeconomic impediment. Introduction of disease specific treatment drugs in the past decade has improved patients’ quality of life and reduced the cost related to hospitalization.Get Sample: https://www.credenceresearch.com/sample-request/58675In 2016, C1 esterase inhibitors segment dominated the market due to the recent approval of novel drugs: Berinert and Haegarda. Additionally, technological advancement in drug delivery (for e.g. Haegarda is the only medication available as a subcutaneous treatment option). Kallikrein inhibitors is expected to be the fastest growing segment throughout the forecast period 2017-2025, majorly due to increasing incidences in patients with severe angioedema anaphylactic shock and promising product pipeline, touted to offer better results than the existing treatment options. The drug in Phase III DX 2930 has received breakthrough therapy designation and orphan drug designation by the USFDA. Phase II drug BCX-7353 is an oral preparation to counteract the severe swelling attacks in the intestinal and airway tract.Leading Players:The key players profiled in this report are BioCryst Pharmaceuticals, Inc., Cipla, Inc., CSL Behring Ltd., Ionis Pharmaceuticals, Inc., iBio, Inc., Merck & Co., Inc., Pharming Group NV, Sanofi N.V., Shire plc, and Teva Pharmaceutical Industries Ltd.ScopeThe report presents the brief overview of Hereditary Angioedema Market including business description, key information and facts, and its locations and subsidiariesThe report features product description and descriptive mechanism of action for key products along with the products developmental history and major milestonesSpecial feature on out-licensed and partnered product portfolioThe report summarizes all the dormant and discontinued projectsLatest company statementLatest news and deals relating to the Hereditary Angioedema productsBrowse Here For Full Report: https://www.credenceresearch.com/report/hereditary-angioedema-marketResearch methodologyThe following research methods were used in this report:Desk studyA questionnaire survey among specialty retail chainsAnalyzing statistical data released by the Federal Customs ServiceDesk study sources include materials taken from print and online media conference materials.Reasons to BuyThe report provides information about technology solutions needed for the implementation of Hereditary Angioedema projects, and allows readers to make effective business decisionsThe report helps readers to strengthen strategic framework by understanding the business benefits to be achieved through Hereditary Angioedema solutionsThe report highlights projected investment on Hereditary Angioedema over the next two years. This will help organizations to allocate budget towards Hereditary Angioedema implementation and business expansionThe report helps executives plan their adoption of Hereditary Angioedema by providing expected timeframes for implementationGet Request For Customization https://www.credenceresearch.com/request-for-customization/58675LinkedIn: https://www.linkedin.com/pulse/single-use-bio-processing-systems-market-global-size-share-pratap/?published=tBriefing wire: https://www.briefingwire.com/pr/single-use-bio-processing-systems-market-examined-in-new-market-research-report